Thyroid lesions incidentally detected by 18F-FDG PET-CT ― a two centre retrospective study
By: Jan Jamsek, Ivana Zagar, Simona Gaberscek and Marko Grmek
References
- 1. Jin J, McHenry CR. Thyroid incidentaloma. Best Pract Res Clin Endocrinol Meta 2012; 26: 83-96.
- 2. Bertagna F, Treglia G, Piccardo A, Giubbini R. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. J Clin Endocrinol Metab 2012; 97: 3866-75.
- 3. Treglia G, Muoio B, Giovanella L, Salvatori M. The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: an overview. Eur Arch Otorhinolaryngol 2012; 270: 1783-7.
- 4. Cistaro A, Quartuccio N, Mojtahedi A, Fania P, Filosso PL, Campenni A, et al. Prediction of 2 years-survival in patients with stage I and II non-small cell lung cancer utilizing (18)F-FDG PET/CT SUV quantification. Radiol Oncol 2013; 47: 219-23.
- 5. Maza S, Buchert R, Brenner W, Munz DL, Thiel E, Korfel A, et al. Brain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma. Radiol Oncol 2013; 47: 103-10.
- 6. Moon E-H, Lim ST, Han Y-H, Jeong YJ, Kang Y-H, Jeong H-J, et al. The usefulness of F-18 FDG PET/CT-mammography for preoperative staging of breast cancer: comparison with conventional PET/CT and MR-mammography.Radiold Oncol; 2013; 47: 390-7.
- 7. Karantanis D, Bogsrud TV, Wiseman GA, Mullan BP, Subramaniam RM, Nathan MA, et al. Clinical Significance of diffusely increased 18F-FDG uptake in the thyroid gland. J Nucl Med 2007; 48: 896-901.
- 8. Kurata S, Ishibashi M, Hiromatsu Y, Kaida H, Miyake I, Uchida M, et al. Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDGPET: prevalence of thyroid cancer and Hashimoto’s thyroiditis. Ann Nucl Med 2007; 21: 325-30.
- 9. Yasuda S, Shohtsu A, Ide M, Takagi S, Takahashi W, Suzuki Y, et al. Chronic thyroiditis: diffuse uptake of FDG at PET. Radiology 1998; 207: 775-8.
- 10. Lowe VJ, Mullan BP, Hay ID, McIver B, Kasperbauer JL. 18F-FDG PET of patients with Hürthle cell carcinoma. J Nucl Med 2003; 44: 1402-6.
- 11. Chen Y-K, Ding H-J, Chen K-T, Chen Y-L, Liao AC, Shen Y-Y, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res 2005; 25: 1421-6.
- 12. Chu QD, Connor MS, Lilien DL, Johnson LW, Turnage RH, Li BDL. Positron emission tomography (PET) positive thyroid incidentaloma: the risk of malignancy observed in a tertiary referral center. Am Surg 2006; 72: 272-5.
- 13. Choi JY, Lee KS, Kim H-J, Shim YM, Kwon OJ, Park K, et al. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med 2006; 47: 609-15.
- 14. Katz SC, Shaha A. PET-associated incidental neoplasms of the thyroid. J Am Coll Surg 2008: 207: 259-64.
- 15. Barnabei A, Ferretti E, Baldelli R, Procaccini A, Spriano G, Appetecchia M. Hurthle cell tumours of the thyroid. Personal experience and review of the literature. Acta Otorhinolaryngol Ital 2009; 29: 305-11.
- 16. Pagano L, Samà MT, Morani F, Prodam F, Rudoni M, Boldorini R, et al. Thyroid incidentaloma identified by ¹8F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. Clin Endocrinol 2011; 75: 528-34.
- 17. Bonabi S, Schmidt F, Broglie MA, Haile SR, Stoeckli SJ. Thyroid incidentalomas in FDG-PET/CT: prevalence and clinical impact. Eur Arch Otorhinolaryngol 2012; 269: 2555-60.
- 18. Ohba K, Sasaki S, Oki Y, Nishizawa S, Matsushita A, Yoshino A, et al. Factors associated with fluorine-18-fluorodeoxyglucose uptake in benign thyroid nodules. Endocr J 2012; 60: 985-90.
- 19. Bertagna F, Treglia G, Piccardo A, Giovannini E, Bosio G, Biasiotto G, et al. F18-FDG-PET/CT thyroid incidentalomas: a wide retrospective analysis in three Italian centres on the significance of focal uptake and SUV value. Endocrine 2013; 43: 678-85.
- 20. Huang SC. Anatomy of SUV. Standardized uptake value. Nucl Med Biol 2000; 27: 643-6.
- 21. Kang BJ, O JH, Baik JH, Jung SL, Park YH, Chung SK. Incidental thyroid uptake on F-18 FDG PET/CT: correlation with ultrasonography and pathology. Ann Nucl Med 2009; 23: 729-37.
- 22. Kim BH, Na MA, Kim IJ, Kim S-J, Kim Y-K. Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation Ann Nucl Med 2010; 24: 721-8.
- 23. Kim TY, Kim WB, Ryu JS, Gong G, Hong SJ, Shong YK. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope 2005; 115: 1074-8.
- 24. Are C, Hsu JF, Ghossein RA, Schöder H, Shah JP, Shaha AR. Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDGPET)- detected incidental thyroid carcinomas. Ann Surg Oncol 2007; 14: 3210-5.
- 25. Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Collins DA, et al. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Nucl Med Comun 2007; 28: 373-81.
- 26. Kwak JY, Kim E-K, Yun M, Cho A, Kim MJ, Son EJ, et al. Thyroid incidentalomas identified by 18F-FDG PET: sonographic correlation. Am J Roentgenol 2008; 91: 598-603.
- 27. Chen W, Parsons M, Torigian DA, Zhuang H, Alavi A. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging. Nucl Med Commun 2009; 30: 240-4.
- 28. Pampaloni MH, Win AZ. Prevalence and Characteristics of Incidentalomas Discovered by Whole Body FDG PETCT. Int J Mol Imaging 2012; 18: 1-6.
- 29. Nguyen NC, Kaushik A, Wolverson MK, Osman MM. Is there a common SUV threshold in oncological FDG PET/CT, at least for some common indications? A retrospective study. Acta Oncol 2011; 50: 670-7.
- 30. de Langen AJ, Vincent A, Velasquez LM, van Tinteren H, Boellaard R, Shankar LK, et al. Repeatability of 18F-FDG uptake measurements in tumors: a metaanalysis. J Nucl Med 2012; 53: 701-8.
- 31. Makris NE, Huisman MC, Kinahan PE, Lammertsma AA, Boellaard R. Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures. Eur J Nucl Med Mol Imaging 2013; 40: 1507-15.
- 32. King D, Stack B, Spring P, Walker R, Bodenner D. Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas. Otolaryngol Head Neck Surg 2007; 137: 400-4.
- 33. Bertagna F, Giubbini R. F18-FDG-PET/CT thyroid incidentalomas and their benign or malignant nature: a critical and debated issue. Ann Nucl Med 2010; 25: 151-2.
- 34. Ohba K, Nishizawa S, Matsushita A, Inubushi M, Nagayama K, Iwaki H, et al. High incidence of thyroid cancer in focal thyroid incidentaloma detected by 18F-fluorodeoxyglucose [corrected] positron emission tomography in relatively young healthy subjects: results of 3-year follow-up. Endocr J 2010; 57: 395-401.
- 35. Nishimori H. Incidental thyroid “PETomas”: clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake. Can J Surg 2011; 54: 83-8.
- 36. Treglia G, Annunziata S, Muoio B, Salvatori M, Ceriani L, Giovanella L. The role of fluorine-18-fluorodeoxyglucose positron emission tomography in aggressive histological subtypes of thyroid cancer: An overview. Int J Endocrinol 2013; 2013: 1-6.
- 37. Zaletel K, Gaberscek S, Pirnat E. Ten-year follow-up of thyroid epidemiology in Slovenia after increase in salt iodization. Croat Med J 2011; 52: 615-21.
- 38. Cooper DS, Haugen BR, Hauger BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167-214.
- 39. Boerner AR, Voth E, Theissen P, Wienhard K, Wagner R, Schicha H. Glucose metabolism of the thyroid in Graves’ disease measured by F-18-fluorodeoxyglucose positron emission tomography. Thyroid 1998; 8: 765-72.
- 40. Liu Y. Clinical significance of thyroid uptake on F18-fluorodeoxyglucose positron emission tomography. Ann Nucl Med 2009; 23: 17-23.
- 41. Ho T-Y, Liou M-J, Lin K-J, Yen T-C. Prevalence and significance of thyroid uptake detected by 18F-FDG PET. Endocrine 2011; 40: 297-302.
Language: English
Page range: 121 - 127
Submitted on: Jun 29, 2014
Accepted on: Sep 22, 2014
Published on: Mar 25, 2015
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2015 Jan Jamsek, Ivana Zagar, Simona Gaberscek, Marko Grmek, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.